1. Adelaide Research & Scholarship

Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 10 (Search time: 0.003 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2005Phase II study of prolonged ambulatory infusion carboplatin and oral etoposide for patients progressing through hormonal therapy for prostate cancerOlver, I.; Keefe, D.; Myers, M.
2016Use of Heart Failure Medical Therapies Among Patients With Left Ventricular Assist Devices: Insights From INTERMACSKhazanie, P.; Hammill, B.G.; Patel, C.B.; Kiernan, M.S.; Cooper, L.B.; Arnold, S.V.; Fendler, T.J.; Spertus, J.A.; Curtis, L.H.; Hernandez, A.F.
2014Impact of reirradiation of painful osseous metastases on quality of life and function: a secondary analysis of the NCIC CTG SC.20 randomized trialChow, E.; Meyer, R.; Chen, B.; van der Linden, Y.; Roos, D.; Hartsell, W.; Hoskin, P.; Wu, J.; Nabid, A.; Tissing-Tan, C.; Oei, B.; Babington, S.; Demas, W.; Wilson, C.; Wong, R.; Brundage, M.
2004Bisphosphonate infusions: patient preference, safety and clinic useChern, B.; Joseph, D.; Joshua, D.; Pittman, K.; Richardson, G.; Schou, M.; Lowe, S.; Copeman, M.; De Abreu Lourenco, R.; Lynch, K.
2000Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosaKlinkenberg-Knol, E.; Nelis, F.; Dent, J.; Snel, P.; Mitchell, B.; Prichard, P.; Lloyd, D.; Havu, N.; Frame, M.; Roman, J.; Walan, A.
2001Acquired haemophilia in South Australia: a case seriesBurnet, S.; Duncan, E.; Lloyd, J.; Han, P.
2012Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: Preclinical evaluation and results of the Phase II DUX Study in chemotherapy-refractory, advanced colorectal cancerWeickhardt, A.; Price, T.; Chong, G.; Gebski, V.; Pavlakis, N.; Johns, T.; Azad, A.; Skrinos, E.; Fluck, K.; Dobrovic, A.; Salemi, R.; Scott, A.; Mariadason, J.; Tebbutt, N.
2011Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up resultsKantarjian, H.; Giles, F.; Bhalla, K.; Pinilla-Ibarz, J.; Larson, R.; Gattermann, N.; Ottmann, O.; Hochhaus, A.; Radich, J.; Saglio, G.; Hughes, T.; Martinelli, G.; Kim, D.; Shou, Y.; Gallagher, N.; Blakesley, R.; Baccarani, M.; Cortes, J.; le Coutre, P.
2004Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancerSuwiwat, S.; Ricciardelli, C.; Tammi, R.; Tammi, M.; Auvinen, P.; Kosma, V.; LeBaron, R.; Raymond, W.; Tilley, W.; Horsfall, D.
2008Analgesic nephropathy and renal replacement therapy in Australia: Trends, Comorbidities and outcomesChang, S.; Mathew, T.; McDonald, S.

Discover